Search
Bionano Genomics Inc
BNGOAdd to Watchlist
1.150USD
-0.020-1.71%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
12.35MMarket Cap
LossP/E TTM
Financial Health
Currency: USD Updated: 2026-07-02 The current financial score of Bionano Genomics Inc is 5.95, ranking 183 out of 204 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 6.69M, representing a year-over-year increase of 3.56%, while its net profit experienced a year-over-year increase of 167.67%.
Financials
5.55
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
7.31
Total revenue
Operating profit
Total assets
SG&A
Relevant data have not been disclosed by the company yet.
Operational Efficiency
4.33
Cash flow from operating activities
Income after tax
Relevant data have not been disclosed by the company yet.
Growth Potential
5.46
Cash flow from operating activities
Total revenue
Relevant data have not been disclosed by the company yet.
Shareholder Returns
7.12
Free cash flow
Relevant data have not been disclosed by the company yet.